Life Sciences

Record damages awarded by Paris court in pemetrexed patent battle

France becoming more friendly to pharma IP, experts suggest, following decision over blockbuster cancer treatment Alimta

Record damages awarded by Paris court in pemetrexed patent battle
EPO plant patent decision imperils businesses like ours, says Bayer’s head of IP
22 Sep 2020

EPO plant patent decision imperils businesses like ours, says Bayer’s head of IP

Joerg Thomaier tells IAM that the Enlarged Board of Appeal got it wrong in a recent controversial ruling, but says the case is now closed and companies have to learn to live with it

40 years after Bayh-Dole, the US government’s patent strategy may be at a turning point
17 Sep 2020

40 years after Bayh-Dole, the US government’s patent strategy may be at a turning point

There is growing pressure on federal agencies to enforce their IP arising from public-private collaborations

Latest

View all
16 Sep 2020

Covid-induced changes are here to stay, Campinos and Iancu agree

Speaking during IPBC Connect plenary session, the EPO and USPTO leaders say there is no going back to the old ways and warn of decreased user engagement caused by the pandemic Read more

15 Sep 2020

Four key takeaways from the latest CRISPR patent wars decision

The Broad Institute gains key advantage in crucial interference battle at the PTAB Read more

14 Sep 2020

Changes to Ukraine’s IP laws have major implications for the life sciences

Two recent pieces of legislation have brought the country’s patent system more closely in line with EU rules Read more

12 Sep 2020

It’s the PTAB, stupid

Whether the US chooses four more years of Donald Trump or Joe Biden replaces him, big tech's assault on the PTO shows where the patent policy battle lines are being drawn Read more

News

View all
5 Sep 2020

Covid-19 shows promise of AI tools – innovators need IP protection, and fast

Breakthroughs by startups across the APAC region show the IP system is working as intended to incentivise innovation - even in a crowded patent landscape Read more

2 Sep 2020

CAFC Illumina clarification is good news for diagnostics innovators

Updated decision increases potential for protecting preparation methods based on natural phenomena under Section 101 Read more

26 Aug 2020

Three lessons from the Federal Circuit’s recent 101 reversal in XY v Trans Ova Genetics

The appellate court overturned an earlier ruling invalidating an animal breeding tech patent Read more

1 Aug 2020

Ignore naysayers, the patent system is playing a vital role in the fight against covid-19

We have learned some important IP lessons in the months since the coronavirus pandemic surged across the world; one of which is just how crucial IP itself is to finding a way out of the crisis Read more

Analysis

View all
11 Sep 2020

Federal Circuit's O’Malley: Supreme Court doesn’t have stomach for another 101 case

In IPBC Connect interview, the CAFC judge also talked about the gutting of injunctive relief in the US and offered her views on recent big ticket European SEP decisions Read more

11 Sep 2020

Top IP owners in telecoms and semiconductors enjoy ongoing share advance

The latest numbers from the US Patent Elite index show stock price rises in both sectors continued into July Read more

10 Sep 2020

PTAB filings increase through the summer while new data points to one possible impact of recent reforms

Rise in reviews comes after district court litigation increases in second quarter; digging deep into the numbers shows interesting trend in number of patents challenged at the board Read more

10 Sep 2020

Pharma patent deal-making may be back with a bang

Following a spate of licensing deals, high-value life sciences M&A now seems to be back in business after a pandemic-induced pause Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more